Acute rejection after paediatric heart transplantation: Far less common and less severe

Transplant International

Volumn 23, Issue 1, 2010, Pages 38-46

  Lammers, Astrid E ^a   Roberts, Philip ^a   Brown, Katherine L ^a   Fenton, Matthew ^a   Rees, Philipp ^a   Sebire, Neil J ^a   Burch, Michael ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Heart transplantation; Immunosuppression; Paediatrics; Rejection

Indexed keywords

AZATHIOPRINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ARTICLE; CARDIAC GRAFT REJECTION; CHILD; EXTRACORPOREAL OXYGENATION; FEMALE; FOLLOW UP; GROUPS BY AGE; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PEDIATRICS; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; GRAFT REJECTION; GREAT BRITAIN; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYCOPHENOLIC ACID; RETROSPECTIVE STUDIES; SIROLIMUS; TACROLIMUS; TREATMENT OUTCOME;

EID: 70949085451     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2009.00941.x     Document Type: Article

References (30)

1. Burra P, De Bona M. Quality of life following organ transplantation. Transpl Int 2007 20 : 397.
2. Spaderna H, Smits JM, Rahmel AO, Weidner G. Psychosocial and behavioural factors in heart transplant candidates - an overview. Transpl Int 2007 20 : 909.
3. Park JB, Kwon CH, Lee KW, et al. Hepatitis B virus vaccine switch program for prevention of de novo hepatitis B virus infection in pediatric patients. Transpl Int 2008 21 : 346.
4. Kocík M, Málek I, Janek B, Zelízko M, Pirk J. Risk factors for the development of coronary artery disease of a grafted heart as detected very early after orthotopic heart transplantation. Transpl Int 2007 20 : 666.
5. Aurora P, Boucek MM, Christie J, et al. Registry of the International Society for Heart and Lung Transplantation: Tenth official pediatric lung and heart/lung transplantation report - 2007. J Heart Lung Transplant 2007 26 : 1223.
6. Boucek MM, Aurora P, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: Tenth official pediatric heart transplantation report - 2007. J Heart Lung Transplant 2007 26 : 796.
7. Dixon V, Macauley C, Burch M, Sebire NJ. Unsuspected rejection episodes on routine surveillance endomyocardial biopsy post-heart transplant in paediatric patients. Pediatr Transplant 2007 11 : 286.
8. Pahl E, Naftel DC, Canter CE, et al. Death after rejection with severe hemodynamic compromise in pediatric heart transplant recipients: A multi-institutional study. J Heart Lung Transplant 2001 20 : 279.
9. Webber SA, Naftel DC, Parker J, et al., Pediatric Heart Transplant Study Group. Late rejection episodes more than 1 year after pediatric heart transplantation: Risk factors and outcomes. J Heart Lung Transplant 2003 22 : 869.
10. Almuti K, Haythe J, Dwyer E, et al. The changing pattern of humoral rejection in cardiac transplant recipients. Transplantation 2007 84 : 498.
11. Mauiyyedi S, Pelle PD, Saidman S, et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001 12 : 574.
12. Smith JD, Hamour IM, Banner NR, Rose ML. C4d fixing, luminex binding antibodies - a new tool for prediction of graft failure after heart transplantation. Am J Transplant 2007 7 : 2809.
13. Casarez TW, Perens G, Williams RJ, et al. Humoral rejection in pediatric orthotopic heart transplantation. J Heart Lung Transplant 2007 26 : 114.
14. Crespo-Leiro MG, Veiga-Barreiro A, Doménech N, et al. Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): incidence, management, and the value of C4d for diagnosis. Am J Transplant 2005 5 : 2560.
15. Kaczmarek I, Deutsch MA, Rohrer ME, et al. HLA-DR matching improves survival after heart transplantation: is it time to change allocation policies? J Heart Lung Transplant 2006 25 : 1057.
16. Waldman TA. Immunotherapy: past, present and future. Nat Med 2003 9 : 269.
17. Billingham M, Kobashigawa JA. The revised ISHLT heart biopsy grading scale. J Heart Lung Transplant 2005 24 : 1709.
18. Ross H, Hendry P, Dipchand A, et al. 2001 Canadian Cardiovascular Society Consensus Conference on cardiac transplantation. Can J Cardiol 2003 19 : 620.
19. Billingham MD, Cary NRB, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990 9 : 587.
20. Dipchand AI, Benson L, McCrindle BW, Coles J, West L. Mycophenolate mofetil in pediatric heart transplant recipients: A single-center experience. Pediatr Transplant 2001 5 : 112.
21. Kobashigawa JA, Miller LW, Russell SD, et al. Study investigators. Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report. Am J Transplant 2006 6 : 1377.
22. Teebken OE, Struber M, Harringer W, Pichlmaier MA, Haverich A. Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients. Transplant Proc 2002 34 : 1265.
23. Fuchs U, Tenderich G, Zittermann A, Szabados F, Minami K, Koerfer R. Clinical outcome of heart transplant recipients receiving tacrolimus with or without mycophenolate mofetil. Clin Transplant 2006 20 : 450.
24. Kim JJ, Dreyer WJ, O'Brian Smith E, et al. Leukocyte suppression is associated with improved clinical outcomes in children's status after orthotopic heart transplantation. J Heart Lung Transplant 2006 25 : 195.
25. Sampaio EL, Pinheiro-Machado PG, Garcia R, et al. Mycophenolate mofetil vs. sirolimus in kidney transplant recipients receiving tacrolimus-based immunosuppressive regimen. Clin Transplant 2008 22 : 141.
26. Ekberg H, Tedesco-Silva H, Demirbas A, et al., ELITE-Symphony Study. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007 357 : 2562.
27. Morales DL, Braud BE, Price JF, et al. Use of mechanical circulatory support in pediatric patients with acute cardiac graft rejection. ASAIO J 2007 53 : 701.
28. Joyce DL, Southard RE, Torre-Amione G, et al. Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes. J Heart Lung Transplant 2005 24 : 2054.
29. Girnita DM, Brooks MM, Webber SA, et al. Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation: A multi-institutional study. Transplantation 2008 85 : 1632.
30. Auerbach SR, Manlhiot C, Reddy S, et al. Recipient genotype is a predictor of allograft cytokine expression and outcomes after pediatric cardiac transplantation. J Am Coll Cardiol 2009 53 : 1909.